AMLo Biosciences (private company)
See something wrong or missing? Let us know
Offices:Newcastle upon Tyne
Industry:BiotechHealth servicesManufacturing
Business model:B2B
AMLo Biosciences is a British medical device startup focused on skin cancer as it has identified two proteins (AMBLor) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.24M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to AMLo Biosciences
Name | Criteria | |
---|---|---|
![]() |
FinnAdvance
65%
|
|
![]() |
Octarine Bio
65%
|
|
![]() |
Molecule.one
65%
|
|
![]() |
Biomes
62%
|
|
![]() |
Sarcura
62%
|
|
![]() |
Uute Scientific Oy
62%
|
|
![]() |
ViveBiotech
62%
|
|
![]() |
CellulaREvolution
62%
|
|
![]() |
ResoTher Pharma
62%
|
|
![]() |
SmartCatch
62%
|
|